Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Chalmette › NPI 1083903744
Hospital

Hospital Service District of the Parish of ST. Bernard, State of Louis

Hospital Service District of the Parish of ST. Bernard, State of Louis was paid $28.92M by Medicaid between Jan 2018 and Dec 2024, across 151 billing codes. Its largest line is 99284, emergency room visit (serious) — 37% of everything it billed.

33Billing provider infoHOSPITAL SERVICE DISTRICT OF THE PARISH OF ST. BERNARD, STATE OF LOUIS
CHALMETTE, LA 70043
33aNPI1083903744assigned 04/04/2011
33bProvider typeRural Acute Care Hospital
28Total paid$28.92M
24GClaims444,671
24DCodes billed151
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Rural Acute Care Hospital providers in Louisiana

Rank by total paid#2 of 8
Median peer was paid$12.38M
This provider vs. median2.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201833,106$3.29M
201946,279$3.83M
202040,766$2.52M
202170,968$3.73M
202289,534$4.84M
202392,940$5.88M
2024incomplete71,078$4.83M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 37% 48,470 44,408 $10.76M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 17% 17,459 15,811 $4.91M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 16% 29,775 27,705 $4.67M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 5.0% 12,740 10,770 $1.45M
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 3.1% 14,747 13,369 $885K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2.9% 17,451 14,565 $830K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2.1% 16,744 15,223 $610K
71045 Radiologic examination, chest; single view 2.0% 13,745 12,417 $580K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.4% 14,398 12,938 $403K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.1% 2,905 2,264 $306K
96375 Therapeutic injection; each additional sequential IV push 1.1% 8,678 7,166 $305K
96361 Intravenous infusion, hydration; each additional hour 1.0% 8,904 6,980 $302K
139 more codes
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 3,292 $263K
80053 Comprehensive metabolic panel <1% 35,802 $249K
70450 Computed tomography, head or brain; without contrast material <1% 2,548 $210K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 34,952 $180K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,035 $168K
81025 <1% 17,478 $124K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 439 $117K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 714 $117K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,599 $113K
G0378 Hospital observation service, per hour <1% 689 $112K
83880 <1% 5,064 $112K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 7,441 $100K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 316 $87K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,231 $86K
84484 <1% 9,395 $68K
80061 Lipid panel <1% 6,253 $61K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 519 $59K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,239 $46K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 11,413 $39K
83690 <1% 7,125 $34K
81001 <1% 14,557 $33K
71046 Radiologic examination, chest; 2 views <1% 793 $32K
36415 Collection of venous blood by venipuncture <1% 15,288 $31K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 1,064 $29K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 361 $28K
83036 Hemoglobin; glycosylated (A1C) <1% 3,917 $26K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,171 $25K
87400 <1% 1,755 $22K
84443 Thyroid stimulating hormone (TSH) <1% 1,963 $21K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 62 $20K
80050 General health panel <1% 625 $19K
73630 <1% 594 $19K
81003 <1% 10,036 $16K
93017 <1% 90 $14K
80305 <1% 1,361 $13K
82607 <1% 983 $11K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 4,227 $11K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,467 $10K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,824 $10K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 329 $10K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 329 $10K
84439 <1% 1,433 $10K
73564 <1% 121 $9K
73562 <1% 295 $9K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 151 $8K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,145 $7K
87081 <1% 1,138 $7K
82962 <1% 2,288 $5K
77067 Screening mammography, bilateral, including computer-aided detection <1% 48 $5K
93225 <1% 101 $5K
80074 <1% 149 $5K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 557 $5K
83735 <1% 1,095 $5K
74018 <1% 97 $4K
87040 <1% 702 $4K
96376 <1% 102 $4K
72100 <1% 112 $4K
86703 <1% 370 $4K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 207 $4K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 18 $4K
83605 <1% 527 $3K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 167 $3K
93226 <1% 101 $3K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,298 $3K
87807 <1% 251 $3K
J7030 Infusion, normal saline solution , 1000 cc <1% 947 $3K
86803 <1% 219 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,032 $2K
80048 Basic metabolic panel (calcium, ionized) <1% 301 $2K
82043 <1% 408 $2K
94060 <1% 14 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,282 $2K
82570 <1% 433 $2K
86140 <1% 485 $2K
85027 <1% 345 $2K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 34 $1K
73610 <1% 51 $1K
85610 <1% 634 $1K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 113 $1K
73130 <1% 43 $1K
94726 <1% 14 $1K
86038 <1% 133 $1K
82550 <1% 245 $1K
73030 <1% 41 $848.63
72040 <1% 13 $846.36
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 31 $757.16
94729 <1% 14 $712.62
J1790 Injection, droperidol, up to 5 mg <1% 218 $677.19
84550 <1% 201 $632.80
84153 <1% 43 $606.87
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 19 $596.53
86592 <1% 170 $552.15
85379 <1% 87 $539.93
J0780 Injection, prochlorperazine, up to 10 mg <1% 58 $493.76
84436 <1% 96 $473.76
87210 <1% 98 $435.75
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 12 $429.36
83970 <1% 15 $412.80
73560 <1% 17 $383.76
87186 <1% 74 $378.67
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 15 $372.84
86431 <1% 97 $370.58
85651 <1% 122 $361.60
87077 <1% 75 $353.67
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 82 $349.26
J1170 Injection, hydromorphone, up to 4 mg <1% 129 $307.69
J1630 Injection, haloperidol, up to 5 mg <1% 119 $288.48
82553 <1% 31 $259.03
J2060 Injection, lorazepam, 2 mg <1% 125 $226.14
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml <1% 13 $203.69
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 55 $180.53
86340 <1% 19 $165.88
80320 <1% 17 $156.00
82746 <1% 12 $147.00
85730 <1% 40 $144.24
82728 <1% 15 $136.30
84466 <1% 12 $127.60
82150 <1% 33 $124.80
36000 <1% 13 $99.72
87088 <1% 14 $64.72
83540 <1% 12 $64.70
J1940 Injection, furosemide, up to 20 mg <1% 14 $42.46
J2550 Injection, promethazine hcl, up to 50 mg <1% 32 $39.90
84156 <1% 13 $22.02
J2704 Injection, propofol, 10 mg <1% 1,393 $20.04
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 14 $19.27
J1650 Injection, enoxaparin sodium, 10 mg <1% 53 $19.17
J0690 Injection, cefazolin sodium, 500 mg <1% 55 $9.45
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 127 $8.61
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 37 $7.97
J3010 Injection, fentanyl citrate, 0.1 mg <1% 154 $2.92
J1596 Injection, glycopyrrolate, 0.1 mg 0% 51 $0.00
00811 0% 32 $0.00
00731 0% 115 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 0% 51 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 150 $0.00
88305 Level IV - Surgical pathology, gross and microscopic examination 0% 535 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 13 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBURKE, TIM (CHIEF EXECUTIVE OFFICER)